SAN ANTONIO, TX and ANN ARBOR, MI, January 8, 2020 – StemBioSys, Inc. (StemBioSys) and CarTox, Inc. (Cartox) are pleased to announce that StemBioSys has acquired a majority stake in Cartox. StemBioSys will acquire all remaining equity of Cartox subject to the achievement of certain milestones. [Read more…]
Stem Cell News
BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.
As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.
Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.
Adaptimmune Receives RMAT Designation for ADP-A2M4 for Synovial Sarcoma
On December 3, 2019, Adaptimmune Therapeutics (Nasdaq:ADAP) announced it has been granted an Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. FDA for ADP-A2M4 in the treatment of Synovial Sarcoma. Previously, the FDA had awarded an Orphan Drug Designation (ODD) to ADP-A2M4 for the treatment of soft tissue sarcomas.
This RMAT designation represents the 38th publicly announced RMAT within the United States. [Read more…]
GIOSTAR Chicago Launches GIOTalk – a New Healthcare Podcast
Program features discussions with key players in the healthcare industry
CHICAGO, Illinois, December 4, 2019 — GIOSTAR Chicago – a leader in regenerative technologies – is proud to introduce GIOTalk, a podcast focusing on stem cells and broader issues impacting the field of healthcare.
Hosted by renowned plastic surgeon Dr. Michael Gellis, GIOTalk features interviews with medical practitioners and researchers, along with patients looking to share their experiences with stem cell therapy. Through these discussions, GIOSTAR Chicago seeks to provide listeners with diverse perspectives on this dynamic industry. [Read more…]
KATAOKA Introduces CPD-017 Cell Processor for High-Speed Biomanufacturing
Unwanted cell removal and cell sorting can be easily performed at high-speed.
TORRANCE, Calif. – Kataoka-SS America, a US subsidiary of Kataoka Corporation Kyoto Japan, has launched its sales of their Cell Processor CPD-017 to the U.S. market. Kataoka`s Cell Processor uses laser technology to scan, identify, and irradiate spontaneously differentiated cells without dissociation or applied stress to the cells.
With the CPD-017, the process time of purifying induced pluripotent stem cell (iPSC) is significantly reduced and the adherent cell colonies can maintain a stress-free healthy condition. [Read more…]
CBR Announces New Pediatric Genetic Screening Test in Collaboration with Sema4
Sema4 collaborated with CBR to launch ReadyGen™, a genetic screening test that analyzes a child’s DNA for 200+ conditions.
LOS ANGELES, Nov. 15, 2019 — CBR, the global leader in newborn stem cell banking, has announced a new genetic service developed over the past couple of years as part of a strategic alliance with Sema4. As a patient-centered health intelligence company and leading innovator within the genomic testing industry, Sema4 collaborated with CBR to launch ReadyGen™, a highly accurate genetic screening test that analyzes a child’s DNA for more than 200 conditions that can affect children before the age of 10. [Read more…]
- « Previous Page
- 1
- …
- 78
- 79
- 80
- 81
- 82
- …
- 122
- Next Page »